Alveolar pentraxin 3 as an early marker of microbiologically confirmed pneumonia: A threshold-finding prospective observational study

Critical Care

Volumn 18, Issue 5, 2014, Pages

  Mauri, Tommaso ^a,b   Coppadoro, Andrea ^a,b   Bombino, Michela ^b   Bellani, Giacomo ^a,b   Zambelli, Vanessa ^a   Fornari, Carla ^a   Berra, Lorenzo ^c   Bittner, Edward A ^c   Schmidt, Ulrich ^c   Sironi, Marina ^d   Bottazzi, Barbara ^d   Brambilla, Paolo ^a   Mantovani, Alberto ^d,e   Pesenti, Antonio ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PENTRAXIN 3; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR; SERUM AMYLOID P;

ADULT; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LUNG LAVAGE; LUNG MYCOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PNEUMONIA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VIRUS PNEUMONIA; AGED; ARTIFICIAL VENTILATION; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; INTENSIVE CARE UNIT; MICROBIOLOGY; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL;

ADULT; AGED; BIOMARKERS; BRONCHOALVEOLAR LAVAGE FLUID; C-REACTIVE PROTEIN; CALCITONIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RESPIRATION, ARTIFICIAL; ROC CURVE; SENSITIVITY AND SPECIFICITY; SERUM AMYLOID P-COMPONENT;

EID: 84988735067     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-014-0562-5     Document Type: Article

References (35)

1. Vincent JL, de Souza Barros D, Cianferoni S: Diagnosis, management and prevention of ventilator-associated pneumonia: an update. Drugs 2010, 70:1927-1944.
2. Horan TC, Andrus M, Dudeck MA: CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332. A published erratum appears in Am J Infect Control 2008, 36:655.
3. Canadian Critical Care Trials Group: A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006, 355:2619-2630.
4. O'Horo JC, Thompson D, Safdar N: Is the Gram stain useful in the microbiologic diagnosis of VAP? A meta-analysis. Clin Infect Dis 2012, 55:551-561.
5. Niederman MS, Soulountsi V: De-escalation therapy: is it valuable for the management of ventilator-associated pneumonia? Clin Chest Med 2011, 32:517-534.
6. American Thoracic Society, Infectious Disease Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
7. Heenen S, Jacobs F, Vincent JL: Antibiotic strategies in severe nosocomial sepsis: Why do we not de-escalate more often? Crit Care Med 2012, 40:1404-1409.
8. Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE: Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004, 350:451-458.
9. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM: Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 1991, 143:1121-1129.
10. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M, PRORATA trial group: Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010, 375:463-474.
11. Tang BM, Eslick GD, Craig JC, McLean AS: Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and metaanalysis. Lancet Infect Dis 2007, 7:210-217.
12. Oudhuis GJ, Beuving J, Bergmans D, Stobberingh EE, ten Velde G, Linssen CF, Verbon A: Soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia. Intensive Care Med 2009, 35:1265-1270.
13. Palazzo SJ, Simpson TA, Simmons JM, Schnapp LM: Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as a diagnostic marker of ventilator-associated pneumonia. Respir Care 2012, 57:2052-2058.
14. Masson S, Caironi P, Spanuth E, Thomae R, Panigada M, Sangiorgi G, Fumagalli R, Mauri T, Isgrò S, Fanizza C, Romero M, Tognoni G, Latini R, Gattinoni L, on behalf of the ALBIOS Study Investigators: Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial. Crit Care 2014, 18:R6.
15. Inforzato A, Bottazzi B, Garlanda C, Valentino S, Mantovani A: Pentraxins in humoral innate immunity. Adv Exp Med Biol 2012, 946:1-20.
16. Mizgerd JP: Acute lower respiratory tract infection. N Engl J Med 2008, 358:716-727.
17. Diamond JM, Meyer NJ, Feng R, Rushefski M, Lederer DJ, Kawut SM, Lee JC, Cantu E, Shah RJ, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Weinacker A, Weill D, Arcasoy S, Shah PD, Belperio JA, Wilkes D, Ware LB, Palmer SM, Christie JD, Lung Transplant Outcomes Group: Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2012, 186:546-552.
18. Moalli F, Paroni M, Véliz Rodriguez T, Riva F, Polentarutti N, Bottazzi B, Valentino S, Mantero S, Nebuloni M, Mantovani A, Bragonzi A, Garlanda C: The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa. J Immunol 2011, 186:5425-5434.
19. Reading PC, Bozza S, Gilbertson B, Tate M, Moretti S, Job ER, Crouch EC, Brooks AG, Brown LE, Bottazzi B, Romani L, Mantovani A: Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J Immunol 2008, 180:3391-3398.
20. Lo Giudice P, Campo S, Verdoliva A, Rivieccio V, Borsini F, De Santis R, Salvatori G: Efficacy of PTX3 in a rat model of invasive aspergillosis. Antimicrob Agents Chemother 2010, 54:4513-4515.
21. Muller B, Peri G, Doni A, Torri V, Landmann R, Bottazzi B, Mantovani A: Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 2001, 29:1404-1407.
22. Mauri T, Bellani G, Patroniti N, Coppadoro A, Peri G, Cuccovillo I, Cugno M, Iapichino G, Gattinoni L, Pesenti A, Mantovani A: Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med 2010, 36:621-629.
23. Sprong T, Peri G, Neeleman C, Mantovani A, Signorini S, van der Meer JW, van Deuren M: Pentraxin 3 and C-reactive protein in severe meningococcal disease. Shock 2009, 31:28-32.
24. Mairuhu AT, Peri G, Setiati TE, Hack CE, Koraka P, Soemantri A, Osterhaus AD, Brandjes DP, van der Meer JW, Mantovani A, van Gorp EC: Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections. J Med Virol 2005, 76:547-552.
25. Lin Q, Fu F, Shen L, Zhu B: Pentraxin 3 in the assessment of ventilatorassociated pneumonia: an early marker of severity. Heart Lung 2013, 42:139-145.
26. Kao SJ, Yang HW, Tsao SM, Cheng CW, Bien MY, Yu MC, Bai KJ, Yang SF, Chien MH: Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia. Clin Chem Lab Med 2013, 51:907-913.
27. Yeo CD, Kim JW, Cho MR, Kang JY, Kim SJ, Kim YK, Lee SH, Park CK, Kim SH, Park MS, Yim HW, Park JY: Pleural fluid pentraxin-3 for the differential diagnosis of pleural effusions. Tuberc Respir Dis (Seoul) 2013, 75:244-249.
28. Mauri T, Coppadoro A, Bellani G, Bombino M, Patroniti N, Peri G, Mantovani A, Pesenti A: Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity. Crit Care Med 2008, 36:2302-2308.
29. Choi SH, Hong SB, Ko GB, Lee Y, Park HJ, Park SY, Moon SM, Cho OH, Park KH, Chong YP, Kim SH, Huh JW, Sung H, Do KH, Lee SO, Kim MN, Jeong JY, Lim CM, Kim YS, Woo JH, Koh Y: Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med 2012, 186:325-332.
30. Jaillon S, Peri G, Delneste Y, Frémaux I, Doni A, Moalli F, Garlanda C, Romani L, Gascan H, Bellocchio S, Bozza S, Cassatella MA, Jeannin P, Mantovani A: The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007, 204:793-804.
31. Shekelle PG, Kahan JP, Bernstein SJ, Leape LL, Kamberg CJ, Park RE: The reproducibility of a method to identify the overuse and underuse of medical procedures. N Engl J Med 1998, 338:1888-1895.
32. Youden WJ: Index for rating diagnostic tests. Cancer 1950, 3:32-35.
33. Bloos F, Marshall JC, Dellinger RP, Vincent JL, Gutierrez G, Rivers E, Balk RA, Laterre PF, Angus DC, Reinhart K, Brunkhorst FM: Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study. Crit Care 2011, 15:R88.
34. Bellani G, Guerra L, Musch G, Zanella A, Patroniti N, Mauri T, Messa C, Pesenti A: Lung regional metabolic activity and gas volume changes induced by tidal ventilation in patients with acute lung injury. Am J Respir Crit Care Med 2011, 183:1193-1199.
35. Cunha C, Aversa F, Lacerda JF, Busca A, Kurzai O, Grube M, Löffler J, Maertens JA, Bell AS, Inforzato A, Barbati E, Almeida B, Santos e Sousa P, Barbui A, Potenza L, Caira M, Rodrigues F, Salvatori G, Pagano L, Luppi M, Mantovani A, Velardi A, Romani L, Carvalho A: Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. N Engl J Med 2014, 370:421-432.